Jason Kelly is the founder of Ginkgo Bioworks. Ginkgo Bioworks has raised $719M in total funding. Latest round: Series E. Based in Boston, Massachusetts.
Jason Kelly is the Co-founder & CEO of Ginkgo Bioworks, a company that specializes in cell programming and synthetic biology. Ginkgo Bioworks has raised a total of $719 million in funding, with their latest Series E round in 2019 bringing in $290 million. The company aims to use biology to transform various industries including materials, clothing, and pharmaceuticals. Kelly and his co-founders met at MIT.
Full founder directory · Investor directory · Company funding database · Fundraising library